Real life experience in mTOR-inhibitors after lung transplantation

S. Bos (Leuven, Belgium), L. De Sadeleer (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), L. Dupont (Leuven, Belgium), L. Godinas (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium)

Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Session: Treatments and biomarkers for lung allograft function and outcome
Session type: Oral Presentation
Number: 4725

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Bos (Leuven, Belgium), L. De Sadeleer (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), L. Dupont (Leuven, Belgium), L. Godinas (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium). Real life experience in mTOR-inhibitors after lung transplantation. 4725

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: